A collaborative approach to successful diagnosis and treatments

Headquartered in Barcelona, WeLab is a leading company specializing in extensive pharmaceutical research and development, prioritizing the delivery of next-generation treatments. They possess expertise in identifying project gaps, defining critical paths, and establishing competitive advantages.
WeLab has granted us the opportunity to expand our presence in the Chinese market and facilitate partnerships between Chinese and European pharmaceutical enterprises. The primary goal is to integrate scientific expertise from both China and Europe and globalize drug research and development efforts.

The objective of this research project is to identify exosomal proteins present in minuscule vesicles in the blood that hold potential clinical application value. The study aims to develop a methodology for recognizing these exosomal proteins with biomarker potential and investigating their involvement in the processes of carcinogenesis and metastasis.
The ultimate goal is to discover novel biomarkers for early cancer diagnosis, disease monitoring, and treatment evaluation, leading to improved patient outcomes. Additionally, this research will contribute to unraveling the mechanisms underlying the role of exosomal proteins in cancer development, laying the groundwork for targeted drug design and the advancement of innovative cancer therapies.

Omega Zeta believes that the existing digital tools and medical education content are insufficient to meet the needs of medical and scientific professionals, educational institutions, professors, and students. In order to address this gap, the company has been dedicated to leveraging technological advancements in the fields of life sciences and healthcare since 2014.
Built on trust, our company is dedicated to promoting Omega Zeta's 3D animated medical education videos in the Chinese market. These videos offer high-quality, easily comprehensible, and in-depth content with the goal of revolutionizing university medical education. By providing physicians with opportunities for continuous learning, we aim to empower them to deliver better and higher-quality care to their patients.